MarketPulse
M

$MYGN

2 articles found
2 positive
0 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Myriad Genetics to Report 2025 Results Amid Precise MRD Launch Preparations

Myriad Genetics reports 2025 results February 23, 2026, while preparing March launch of Precise MRD cancer detection product. Strong clinical data supports expansion.
MYGNQ4 2025 earnings2026 guidance
GlobeNewswire Inc.GlobeNewswire Inc.··Towards Healthcare

SNP Genotyping Market Poised to Double to $19.5B by 2034

SNP genotyping market projected to grow from $8.08B (2026) to $19.48B (2034) at 11.7% annual rate, driven by personalized medicine adoption and genomic technology advances.
ILMNRHHBYTMOREGNMYGNpersonalized medicineprecision medicine